Position in TGTX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$4,403,475
+$469,987 QoQ
Shares Held
132,555
+0.5% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BESSEMER GROUP INC holds $174,191,136 across 88 Biotechnology names. TGTX ranks #12 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
64,251 | $46,919,290 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
107,859 | $21,534,046 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
708,398 | $14,819,686 | |
| 4 | MAZE |
Maze Therapeutics, Inc.
|
481,790 | $14,381,431 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
54,178 | $5,710,360 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
20,285 | $5,240,020 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
89,439 | $5,052,409 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
79,140 | $4,962,077 |
All Filings in TGTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,403,475 | 132,555 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $3,933,488 | 131,952 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $32,547 | 901 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $14,935 | 415 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $15,732 | 399 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $8,187 | 272 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,204 | 137 | Shares | Defined | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||